Adding 2% glucose to culture media does not influence the activity of caspofungin against Candida species

被引：2

作者：

Laverdiere, M ^{[1
]}

Restieri, C ^{[1
]}

Habel, F ^{[1
]}

机构：

[1] Hop Maison Neuve Rosemont, Dept Microbiol & Infect Dis, Montreal, PQ H1T 2M4, Canada

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2003年 / 51卷 / 01期

关键词：

D O I：

10.1093/jac/dkg021

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：183 / U17

页数：2

共 6 条

[1] Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp. [J].

Cuenca-Estrella, M ;

Díaz-Guerra, TM ;

Mellado, E ;

Rodríguez-Tudela, JL .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (02) :525-532

[2] In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts [J].

Galgiani, JN ;

Lewis, ML .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :180-183

[3] INVITRO AND INVIVO ANTI-CANDIDA ACTIVITY AND TOXICOLOGY OF LY121019 [J].

GORDEE, RS ;

ZECKNER, DJ ;

ELLIS, LF ;

THAKKAR, AL ;

HOWARD, LC .

JOURNAL OF ANTIBIOTICS, 1984, 37 (09) :1054-1065

[4] Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans [J].

Krishnarao, TV ;

Galgiani, JN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :1957-1960

[5]

NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS-NCCLS, 1997, M27A NCCLS

[6] In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents [J].

Pfaller, MA ;

Messer, SA ;

Coffman, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) :763-766

← 1 →